The global minimally invasive surgery market is expected to grow at a CAGR of around 9.6% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 33.8 Bn by 2026.
Minimally invasive surgery uses techniques to operate with less incision or damage to the body than open surgery. Hence, it is associated with less pain, fewer postoperative complications, and shorter hospital stays. Some of the minimally invasive surgeries are done by using robotic technology that allows more control over the surgery. Surgeons are performing various surgeries using a minimally invasive technique such as Adrenalectomy, cancer surgery, Colectomy, ear, nose, and throat surgery, heart surgery, kidney transplant, gynecology surgery, endovascular surgery, orthopedic surgery, urologic surgery, Splenectomy, and thoracic surgery. Minimally invasive surgeries are majorly performed at government and private hospitals, ambulatory surgical centers, and research institutes.
The minimally invasive surgery market is growing due to innovative advancements, in the fields of orthopedic, cardiac, neurological, ophthalmic, and robotic surgical procedures. The constant technological advancements in MIS provide innovative and higher-quality instruments that enable the surgeons to execute surgical interventions efficiently with the highest patient safety. Investment by market players to develop advanced product designs that provide a high level of accuracy and control in the operating room are likely to boost the market growth.
The cost of MIS is significantly lesser than open surgeries with better outcomes resulting in a significant increase in the demand from the lower-income countries as well. Investment by market players in the developing regions due to the presence of the largest targeted patient population is likely to propel the market growth. Ambulatory centers prefer performing MIS as they facilitate same-day-discharge to patients and an increasing number of ambulatory surgery centers across the world to decrease the burden on hospitals is anticipated to boost the market in the coming years.
Based on the product, the minimally invasive surgery market is divided into handheld instruments, electrosurgical instruments, guiding devices, inflation systems, auxiliary instruments, and cutter instruments. The handheld instrument segment accounted for the largest share of the market in 2018. Technological advancement, low cost devices, and ability to ensure easier access during surgery without damage to patient’s body are the key factors for the high demand of handheld instruments. Application of these instruments in wide range of minimally invasive surgeries is anticipated to boost the market in coming years as well.
Based on the application, the market has been segmented into cardiothoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgery, vascular surgery, cosmetic/bariatric surgery, urological surgery, and others. Others segment include dental surgery, ENT/respiratory surgery, and neurological surgery. Orthopedic surgeries accounted for the maximum share of the market in 2018 due to large volume of surgeries, development of various minimally invasive surgeries for orthopedic injuries, and introduction of MIS approach in knee and hip replacement process. However, increasing number of cardiothoracic disease patients is expected to propel the minimally invasive surgery market at the fastest rate.
End User Study
Based on the end user, the market has been categorized into hospitals, ambulatory surgery centers, and research institutes. Hospitals accounted for the major share of the market in 2018. However, ambulatory surgery centers are expected to observe the fastest growth during the forecast period as these centers offer surgeries at greater flexibility of scheduling and lower costs as compared to hospitals.
Geographically, North America held the largest share of the market in 2018 and is anticipated to maintain its dominance during the forecast period. This can be attributed to high adoption of minimally invasive surgeries due to technological advancement, more awareness about minimally invasive surgery’s advantages such as reducing surgery time, minimal or no surgical incision, lesser chance of surgical site infection, and decreased in overall healthcare cost, presence of abundant ambulatory surgery centers, local presence of market players, and availability of reimbursement for these surgeries. However, Asia Pacific is expected to witness the fastest growth during the forecast period due to large volume of targeted patients, investment by market players, increasing healthcare expenditure and technological adoption, supportive government regulations for the approval & commercialization of noninvasive devices, and growing disposable income. For instance, in November 2017, Johnson & Johnson’s Ethicon opened a facility in China with an investment of USD 180 million. The factory is expected to start its production of open surgical and minimally invasive solutions in 2019.
The market research study on “Minimally Invasive Surgery Market – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 – 2026”, offers a detailed insight on the global minimally invasive surgery market entailing insights on its different market segments. Market dynamics with drivers, restraints, and opportunities with their impact are provided in the report. The report provides insights into the global minimally invasive surgery market, its product, its application, end user, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global minimally invasive surgery market size and segment markets by product, by application, by end user, and geography along with the information on companies operating in the market. The minimally invasive surgery market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market sizes for different segments have been covered under the scope of the report.
The players profiled in the report include Abbott, CONMED, Medtronic, Smith & Nephew, Stryker, NuVasive, Inc., Intuitive Surgical, Inc.; and Zimmer Biomet. The competitors are involved in the innovative product development and commercialization, mergers, acquisitions, and collaborations to enhance their footprints in the market.
By End User
Minimally invasive surgery uses techniques to operate with less incision or damage to the body than open surgery.
According to Acumen Research and Consulting, the minimally invasive surgery market value is anticipated to be around US$ 33.8 Bn in 2026.
The minimally invasive surgery market is anticipated to grow over 9.6% CAGR during the forecast period 2019 to 2026.
The minimally invasive surgery market is growing due to innovative advancements, in the fields of orthopedic, cardiac, neurological, ophthalmic, and robotic surgical procedures.
Asia Pacific is expected to witness the fastest growth during the forecast period due to large volume of targeted patients, investment by market players, increasing healthcare expenditure and technological adoption, supportive government regulations for the approval & commercialization of noninvasive devices, and growing disposable income.
Abbott, CONMED, Medtronic, Smith & Nephew, Stryker, NuVasive, Inc., Intuitive Surgical, Inc.; and Zimmer Biomet are the top players operating in the minimally invasive surgery market.